ADVENTRX Pharmaceuticals to Present at the Lippert/Heilshorn Life Sciences Virtual Conference

SAN DIEGO, Dec. 9  /PRNewswire-FirstCall/ -- ADVENTRX Pharmaceuticals, Inc. (NYSE Amex: ANX) today announced that the Company's Principal Executive Officer, Brian M. Culley, will present to investors as part of the Lippert/Heilshorn & Associates Life Sciences On-line Forum on December 15, 2009 at 9:30 a.m. Eastern time.

Interested parties can access a live audio webcast with slide presentation at http://www.informedinvestors.com/, a link to which is available on the ADVENTRX Pharmaceuticals Web site at http://www.adventrx.com/.  An archived presentation will be available for 30 days.

About ADVENTRX Pharmaceuticals

ADVENTRX Pharmaceuticals is a specialty pharmaceutical company whose product candidates are designed to improve the performance of existing cancer treatments by addressing limitations associated principally with their safety and use.  More information can be found on the Company's web site at http://www.adventrx.com/. 

DATASOURCE: ADVENTRX Pharmaceuticals, Inc.



CONTACT:  Brian Culley, Principal Executive Officer of ADVENTRX

Pharmaceuticals, [phone]; or investors, Don Markley of

Lippert/Heilshorn & Associates, Inc., [phone], , for

ADVENTRX Pharmaceuticals, Inc.



Web Site:  http://www.adventrx.com/ 

Copyright